Knobil Katharine 4
4 · Marker Therapeutics, Inc. · Filed Dec 9, 2021
Insider Transaction Report
Form 4
Knobil Katharine
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-12-08+125,000→ 125,000 totalExercise: $1.20Exp: 2031-12-07→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a three-year period commencing on January 8, 2022, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.